Evidence map›Paper›PMID 33080336›Full record

ReviewNeurobiology of disease2020

Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-sphingolipids.

S Gowrishankar, S M Cologna, M I Givogri, E R Bongarzone

Open access · goldAbstract readReview
In one paragraph

Review in Neurobiology of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Loss of MAPK8IP3 Affects Endocytosis in Neurons.Frontiers in cellular neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

S GowrishankarDepartment of Anatomy and Cell Biology, University of Illinois, Chicago, IL, USA. Electronic address: swethag@uic.edu.
S M ColognaDepartment of Chemistry, University of Illinois, Chicago, IL, USA. Electronic address: cologna@uic.edu.
M I GivogriDepartment of Anatomy and Cell Biology, University of Illinois, Chicago, IL, USA. Electronic address: mgivogri@uic.edu.
E R BongarzoneDepartment of Anatomy and Cell Biology, University of Illinois, Chicago, IL, USA. Electronic address: ebongarz@uic.edu.
Illinois College · USUniversity of Illinois Chicago · US

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
Combined Neuroprotection and Metabolic Correction to Treat LeukodystrophiesR01NS065808 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONGARZONE, ERNESTO ROQUE · 2009 to 2018
$3.0M
NCATS NIH HHS UL1 TR002003NINDS NIH HHS R01 NS065808
6 · The paper itself

Abstract

The role of lipids in neuroglial function is gaining momentum in part due to a better understanding of how many lipid species contribute to key cellular signalling pathways at the membrane level. The description of lipid rafts as membrane domains composed by defined classes of lipids such as cholesterol and sphingolipids has greatly helped in our understanding of how cellular signalling can be regulated and compartmentalized in neurons and glial cells. Genetic conditions affecting the metabolism of these lipids greatly impact on how some of these signalling pathways work, providing a context to understand the biological function of the lipid. Expectedly, abnormal metabolism of several lipids such as cholesterol and galactosyl-sphingolipids observed in several metabolic conditions involving lysosomal dysfunction are often accompanied by neuronal and myelin dysfunction. This review will discuss the role of lysosomal biology in the context of deficiencies in the metabolism of cholesterol and galactosyl-sphingolipids and their impact on neural function in three genetic disorders: Niemann-Pick type C, Metachromatic leukodystrophy and Krabbe's disease.

Indexed as

AnimalsCholesterolHumansLeukodystrophy, Globoid CellLysosomesNeuronsPsychosineSphingolipidsCholesterolPsychosineSphingolipidsAktCholesterolEndosomeExosomeKrabbe's diseaseLipid raftLipidsLysosomesMetabolismMetachromatic leukodystrophyMyelinNiemann-Pick type C diseasePsychosineSignallingSulfatides

Identifiers

PMID33080336
PMCPMC8862610
OpenAlexW3093300040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.